SENSEX
NIFTY
GOLD
USD/INR

Weather

image 39    C

Top News News

The Hindu

Top News / The Hindu

details

Trial for Bundibugyo Ebola treatment starts in DRC, WHO says

The trial will evaluate Mapp Biopharmaceutical's experimental MBP134 antibody as a standalone treatment for Bundibugyo Ebola, as well as in combination with Gilead Sciences' antiviral drug remdesivir, the WHO said

4 Jul 2026 2:07 pm